                         SEQUENCE LISTING

<110>  Yissum Research Development Company of the Hebrew
       Hadasit Medical Research Services and Development Ltd.
 
<120>  NEUTROPHIL-BINDING PEPTIDES

<130>  IMUX-P-001-PCT

<150>  63/045,107
<151>  2020-06-28

<160>  18    

<170>  PatentIn version 3.5

<210>  1
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  1

Lys Phe Pro Asp Leu Asp Ser Arg Arg Leu Pro His Met Ser Leu 
1               5                   10                  15  


<210>  2
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  2

Leu Ala Thr Thr His Met Val Phe Ser Pro Asp His 
1               5                   10          


<210>  3
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  3

Pro Ser Ser Asn Leu Glu Ser Thr Pro Leu Ser Leu Leu 
1               5                   10              


<210>  4
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  4

Ser Ser Leu Met Thr Thr Gln Leu Ile Ala Thr Ser Ile 
1               5                   10              


<210>  5
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  5

Pro Glu Leu Asp Ser Lys Pro Tyr Phe Pro Pro Leu 
1               5                   10          


<210>  6
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  6

Glu Leu Val Thr Ala Ser Met Pro Arg Pro Asn Asn 
1               5                   10          


<210>  7
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  7

Ser Leu Glu Ser Ser Pro Met Ala Gln Leu Pro Gln 
1               5                   10          


<210>  8
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  8

Ser Glu Leu Arg Ser Thr Pro Leu Leu Val Pro Ser 
1               5                   10          


<210>  9
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  9

Leu Gln Ile Gln Ser Trp Ser Ser Ser Pro 
1               5                   10  


<210>  10
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  10

Ser Thr Met Thr Ile Leu Gly Thr Gly Ser 
1               5                   10  


<210>  11
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  11

Thr Glu Thr Ser Leu Arg Ile Val Ser Thr Asn Pro 
1               5                   10          


<210>  12
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  12

Leu Ser Ile Val Ser Gly Ser Ala Leu Asn His Leu 
1               5                   10          


<210>  13
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  13

Leu Thr Leu Val Ser Glu Arg Pro Met Ile 
1               5                   10  


<210>  14
<211>  32
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  14

Met Leu Ser Phe Ala Ala Glu Gly Gly Gln Arg Gly Leu Gln Ile Gln 
1               5                   10                  15      


Ser Trp Ser Ser Ser Pro Ala Ala Gly Ala Asp Pro Ala Lys Ala Ala 
            20                  25                  30          


<210>  15
<211>  19
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  15

Gly Gly Gly Ser Arg Gly Leu Gln Ile Gln Ser Trp Ser Ser Ser Pro 
1               5                   10                  15      


Ala Ala Gly 
            


<210>  16
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  16

Lys Ala Lys Ala 
1               


<210>  17
<211>  4
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  17

Gly Gly Gly Ser 
1               


<210>  18
<211>  5
<212>  PRT
<213>  Artificial

<220>
<223>  Synthetic

<400>  18

Gly Gly Gly Gly Ser 
1               5   


